Release Date: 13/12/13 09:13 Summary: Notice of variation - Extension of offer period Price Sensitive: Yes Download Document 405.58KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%